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Abstract We have deleted the yeast gene YJR025c and shown
that this leads to an auxotrophy for nicotinic acid. The deduced
protein sequence of the gene product is homologous to the human
3-hydroxyanthranilic acid dioxygenase (EC 1.13.11.6) which is
part of the kynurenine pathway for the degradation of
tryptophan and the biosynthesis of nicotinic acid. In cell-free
extracts the 3-hydroxyanthranilic acid dioxygenase activity is
proportional to the copy number of the YJR025c gene. As
YJR025c encodes the yeast 3-hydroxyanthranilic acid dioxygen-
ase, we have named this gene BNA1 for biosynthesis of nicotinic
acid.
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1. Introduction
During the systematic sequencing of the genome of Saccha-
romyces cerevisiae we identi¢ed the gene YJR025c on chro-
mosome X [1]. Analysis of the sequence revealed strong sim-
ilarities to the human 3-hydroxyanthranilic acid dioxygenase
(EC 1.13.11.6; 3-HOA). This enzyme was initially character-
ized and puri¢ed from bovine liver and kidney [2^4], and is
involved in the catabolism of tryptophan via the kynurenine
pathway. Precursors for the biosynthesis of the nicotinamide
moiety of NAD may also be provided by this pathway. Re-
cently, kynurenine metabolites have been implicated in several
neuropathological conditions (see [5] for a review). This has
led to the cloning and characterization of the human 3-HOA
[6]. Here we present genetic and biochemical evidence that
YJR025c encodes the yeast 3-HOA.
2. Materials and methods
2.1. Strains, media and genetic methods
The Escherichia coli strain used was DH5KFP (supE44, vlacU169
{x80 lacZvM15} hsdR17, recA1, endA1, gyrA96, thi-1, relA1, FP), the
media used for the propagation of E. coli were as described in [7]. The
S. cerevisiae strains used were all derived from the homozygous dip-
loid strain W303 (MATK/MATK, ade2-1, his3-11, 15, leu2-3, 12, trp1-
1, ura3-1, can1-100) [8] and are described in the text. The media used
for the cultivation of yeast were as described in [9]. Nicotinic acid was
added to the G0 synthetic minimal medium at a concentration of 0.5
Wg/ml. Solid G0 medium was made by adding 1.5% agarose. Standard
genetic manipulations of yeast were performed as described in [10].
2.2. Preparation of cell-free extracts and 3-hydroxyanthranilic acid
dioxygenase assays
Cells were grown to early stationary phase in G0 synthetic minimal
medium containing nicotinic acid, harvested, washed and resuspended
in 33 mM Tris-HCl. The cells were disrupted in a Brown homogenizer
for 2 min, centrifuged for 5 min at 4‡C in a microfuge and super-
natant was passed over a G25 NAP column (Pharmacia) equilibrated
with 33 mM Tris-HCl. This desalted extract was used for 3-HOA
assays as described [2]. The product, 2-amino-3-carboxymuconic
acid semialdehyde, was measured at 360 nm and a molar extinction
coe⁄cient of 47 500 M31 cm31 was used for the calculation of the
activity. Proteins were assayed using the method of Lowry [11].
2.3. Nucleic acid manipulation and transformation
Restriction enzymes, Taq DNA polymerase and T4 DNA ligase
were obtained from standard sources and were used in accordance
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Fig. 1. Simpli¢ed schematic view of the intermediates and enzymes
involved in the kynurenine pathway.
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Fig. 2. A: Growth of wild type, BNA1 deleted and BNA1 deleted/complemented strains on solid G0 minimal medium without nicotinic acid.
The plate was incubated at 28‡C for three days. B: Growth of wild type (RK02-2A a and RK02-2B E) and BNA1 deleted strains (RK02-2C
7 and RK02-2D O) on liquid G0 minimal medium without nicotinic acid. C: Growth of wild type (RK02-2A a and RK02-2B E) and BNA1
deleted/complemented strains (RK02-2C/RKYCp002 8 and RK02-2D/RKYCp002 R) on liquid G0 minimal medium without nicotinic acid.
Fig. 3. A: Speci¢c activity of 3-HOA in cell extracts. The speci¢c activity is expressed as mmol of 2-amino-3-carboxymuconic acid semialde-
hyde produced per min per mg of protein. The ¢gure in parentheses indicates the number of independent determinations. B, C: Determination
of the Km for 3-hydroxyanthranilic acid in cell extracts RK02-1B (BNA1) 19.2 WM and RK02-2C (bna1v : :HIS3)/RKYCp002 15.9 WM.
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with the manufacturers’ instructions. Southern blot analysis was per-
formed as described [12] using radiolabelled probes made with the
Amersham Megaprime DNA kit. E. coli was transformed using the
CaCl2/RbCl2 method or by electroporation [12]. Yeast was trans-
formed using the LiCl procedure [13].
2.4. Plasmid construction and deletion of the gene YJR025c
The wild type YJR025c gene was cloned as a 1709 bp HindIII-XhoI
fragment, derived from the cosmid pEJ103 [1]. This fragment was
cloned into the HindIII-XhoI sites of the centromeric plasmid
pRS416 to give RKYCp002 and the HindIII-SalI sites of the multi-
copy plasmid YEp352 to give RKYEp003. All plasmids carry a URA3
marker for selection in yeast. To delete the chromosomal copy of the
YJR025c gene the method of Reiger et al. [14] was used. The HIS3
gene was ampli¢ed by PCR using hybrid primers that contained long
tails (V50 bp) identical to the extremities of the YJR025c gene: oligo-
pro AGGCCTTTTGAAACCACCGGTGAATAATTATTGCTTAC-
ATAAAGGGGGATTCGTTCAGAATGACACG; oligo-term TTA-
ATTAGATTGAGGGCGTGCGTAGTTTAACGTCTTGCAATGG-
AAACATGCTCTTGGCCTCCTCTAG.
In the resulting fragment a 384 bp region of the coding sequence of
the YJR025c gene has been replaced by 1108 bp encoding the HIS3
gene. This PCR product was used to transform the yeast strain W303,
histidine prototrophs were selected and screened by PCR to determine
if the integration had occurred at the YJR025c locus.
3. Results and discussion
As a ¢rst step in our analysis of YJR025c we decided to
delete the chromosomal copy of the gene in the diploid strain
W303. This was done using a PCR based strategy as described
in Section 2. A tetrad analysis of the resulting heterozygous
diploid, RK02, showed that the gene was not essential. We
had previously noted a strong similarity between the predicted
product of YJR025c and human 3-HOA [1], an enzyme of the
kynurenine pathway. This suggested that YJR025c may be
involved in the degradation of tryptophan and the biosynthe-
sis of nicotinic acid (see Fig. 1). To test this hypothesis the
wild type strain and strains with a deleted YJR025c gene were
grown on G0 minimal medium in the presence and absence of
0.5 Wg/ml nicotinic acid. The results in Fig. 2 show that in
liquid medium the strains with a deleted YJR025c gene were
unable to grow in the absence of added nicotinic acid, on solid
medium some residual growth was seen. In both cases a wild
type level of growth was restored when the deleted strains
were transformed by the plasmid RKYCp002, a centromeric
plasmid which carries the wild type YJR025c gene.
In order to determine if the nicotinic acid auxotrophy of the
YJR025c deleted strains was due to a de¢ciency in 3-HOA,
the activity of the enzyme was determined in cell-free extracts
made from a wild type strain, a strain with a deleted YJR025c
gene and YJR025c deleted strains carrying the wild type gene
on a centromeric plasmid (RKYCp002) or a multicopy plas-
mid (RKYEp003). The results in Fig. 3A show that in the
deleted non-complemented strain 3-HOA activity cannot be
detected and that in the other strains 3-HOA activity is pro-
portional to the copy number of the YJR025c gene.
In a ¢nal series of experiments the Km for 3-hydroxyanthra-
nilic acid was determined in cell-free extracts of a wild type
strain and a YJR025c deleted strain carrying the wild type
gene on a centromeric plasmid (RKYCp002). The results
are presented in Fig. 3B,C. The Km values observed, 19.2
WM (wild type strain) and 15.9 WM (deleted complemented
strain), are similar to those obtained previously: 26 WM for
bovine liver enzyme [2], 5.6 WM for rat liver enzyme and 2.3
WM for the cloned human enzyme [6].
Taken together these results clearly demonstrate that
YJR025c encodes 3-HOA, an enzyme of the kynurenine path-
way of tryptophan degradation, and that in yeast this enzyme
is involved in the biosynthesis of nicotinic acid. We propose
that the gene be called BNA1 (biosynthesis of nicotinic acid).
Previously Ahmad and Moat [15] demonstrated that under
aerobic conditions nicotinic acid is derived from tryptophan
via quinolinic acid and were able to detect two enzymes of the
kynurenine pathway in cell extracts. With the completion
of the sequence of the yeast genome sequence it is now pos-
sible to tentatively identify the genes encoding some other
enzymes in this pathway: YBL098w (kynurenine 3-hydroxy-
lase, EC 1.14.13.9), YLR231c (kynureninase, EC 3.7.1.3) and
YFR047c (quinolinic acid phosphoribosyltransferase, EC
2.4.2.19) (see Fig. 1). Our sequence analysis suggests that
yeast does not contain a tryptophan 2,3-dioxygenase and to
our knowledge no sequence data are available for indoleamine
2,3-dioxygenase or kynurenine formamidase to allow compar-
isons to be made, but kynurenine formamidase activity has
been detected in yeast [15]. Thus there is some evidence for the
existence of most of the enzymes of the kynurenine pathway
in yeast.
The reason for the leaky growth of the BNA1 deleted
strains see in Fig. 2 remains unclear. This growth may be
due to residual nicotinic acid in the medium, but this is un-
likely as a completely de¢ned medium solidi¢ed with agarose
was used. Ahmad and Moat [15] provided evidence for an
alternative pathway of nicotinic acid biosynthesis from as-
partic acid or glutamic acid which operates under anaerobic
conditions and it is possible that this pathway may be respon-
sible for the residual growth of the BNA1 deleted strains.
We have presented the ¢rst genetic evidence for the exist-
ence of the kynurenine pathway of tryptophan degradation
and nicotinic acid biosynthesis in yeast and partially charac-
terized the 3-hydroxyanthranilic acid dioxygenase. This study
also shows how the availability of the complete sequence of
the yeast genome can facilitate metabolic studies and should
lead to a rapid increase in our understanding of intermediary
metabolism in yeast.
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